Skip to main navigation Skip to search Skip to main content

Discovery of a 3-amino-6-phenyl-pyridazine derivative as a new synthetic antineuroinflammatory compound

  • Salida Mirzoeva
  • , Anu Sawkar
  • , Magdalena Zasadzki
  • , Ling Guo
  • , Anastasia V. Velentza
  • , Vincent Dunlap
  • , Jean Jacques Bourguignonl
  • , Helena Ramstrom
  • , Jacques Haiech
  • , Linda J. Van Eldik
  • , D. M. Watterson

Research output: Contribution to journalArticlepeer-review

60 Scopus citations

Abstract

Excessive glial activation, with overproduction of cytokines and oxidative stress products, is detrimental and a hallmark of neurodegenerative disease pathology. Suppression of glial activation is a potential therapeutic approach, and protein kinases are targets of some antiinflammatory drugs. To address an unmet need for selective inhibitors of glial activation, we developed a novel 3-amino-6-phenylpyridazine derivative that selectively blocks increased IL-1β, iNOS, and NO production by activated glia, without inhibition of potentially beneficial glial functions.

Original languageEnglish
Pages (from-to)563-566
Number of pages4
JournalJournal of Medicinal Chemistry
Volume45
Issue number3
DOIs
StatePublished - Jan 31 2002

Funding

FundersFunder number
National Institute on AgingR37AG013939

    ASJC Scopus subject areas

    • Molecular Medicine
    • Drug Discovery

    Fingerprint

    Dive into the research topics of 'Discovery of a 3-amino-6-phenyl-pyridazine derivative as a new synthetic antineuroinflammatory compound'. Together they form a unique fingerprint.

    Cite this